The APL is 1 kind of AML characterized by the balanced reciprocal translocation between the promyelocytic leukemia gene on chromosome 15 and the retinoic acid receptor α (RARα) gene on chromosome 17, and accounts for 10% to 15% of newly diagnosed AML each year. Here, RARA is linked to acute myeloid leukemia.